Workshop on Glioblastoma

PSCC Connect invites members of PSCC Connect Community and selected partners to an exclusive workshop dedicated to Glioblastoma

🎯 Objective

This workshop will aim to explore several key topics in depth through working groups (currently being organised), including:

• Definition of alternative endpoints to OS

• Combinatorial approaches, regulatory strategies and market access strategies

• Drafting a guide for biotech and medtech companies wishing to position themselves in this indication (including, in particular, the regulatory roadmap, available fast-track pathways, recommendations on trial design and the integration of new endpoints, recommendations for convincing investors and pharmaceutical companies, as well as a market data kit by indication)

The aim is to identify concrete avenues for further consideration, with the possibility of developing one or more joint deliverables, which could, for example, include:

• A framework guide for biotech/medtech stakeholders

• A white paper dedicated to endpoints

• Possibly a more ambitious initiative on combination approaches (e.g. funding a platform trial)

Event exclusively upon invitation for PSCC Connect members.